PURE Bioscience, Inc. (OTCMKTS:PURE – Get Rating)'s share price passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.20 and traded as high as $0.23. PURE Bioscience shares last traded at $0.22, with a volume of 212,326 shares.

PURE Bioscience Price Performance

The company has a market cap of $19.37 million, a price-to-earnings ratio of -5.50 and a beta of 0.01. The business has a 50 day simple moving average of $0.21 and a 200 day simple moving average of $0.20.

PURE Bioscience (OTCMKTS:PURE – Get Rating) last announced its quarterly earnings results on Tuesday, June 14th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business had revenue of $0.50 million during the quarter. PURE Bioscience had a negative return on equity of 131.39% and a negative net margin of 131.59%.

PURE Bioscience Company Profile

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.

Featured Stories

• Get a free copy of the StockNews.com research report on PURE Bioscience (PURE)
• Darden Restaurants Takes the Low Road Against Inflation
• Why These 3 Stocks Are Off to Hot September Starts
• Inflation Doesn't Differentiate, But it's Impact Does
• 3 Downgraded Must-Have Stocks To Put On Your Watchlist
• This Is What To Expect From The Q3 Earnings Reporting Season

Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.